Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply

Detalles Bibliográficos
Autores principales: Nakaoka, Yoshikazu, Yamashita, Katsuhisa, Yamakido, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Matters Arising
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449802/
https://www.ncbi.nlm.nih.gov/pubmed/32594147
http://dx.doi.org/10.1093/rheumatology/keaa255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449802/
https://www.ncbi.nlm.nih.gov/pubmed/32594147
http://dx.doi.org/10.1093/rheumatology/keaa255

Ejemplares similares